Kai Zhang, Shuimiao Wei, Ruixue Wang, Ailing Li, Nan Zhang, Cuiping Ni
{"title":"Cognitive frailty in maintenance hemodialysis: a scoping review.","authors":"Kai Zhang, Shuimiao Wei, Ruixue Wang, Ailing Li, Nan Zhang, Cuiping Ni","doi":"10.1007/s11255-025-04361-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To conduct a scoping review of the related research on cognitive frailty (CF) in maintenance hemodialysis (MHD) patients, so as to provide a basis for early diagnosis, treatment and intervention of CF in MHD patients.</p><p><strong>Methods: </strong>Utilizing a scoping review approach, we searched PubMed, Embase, The Cochrane Library, Web of Science, CINAHL, the China Biological Medicine Database (CBM), China National Knowledge Infrastructure (CNKI), Wanfang, and Weipu (VIP) for literature on CF in MHD patients up to October 20, 2024. Two researchers conducted independent screening and data extraction of the literature's fundamental characteristics. The study is registered in OSF ( https://doi.org/10.17605/OSF.IO/H6Q89 ).</p><p><strong>Results: </strong>The review included 21 articles, revealing a concerningly high prevalence of CF in MHD patients, ranging from 4.6 to 56.4%. Six diagnostic combinations were identified, with the combination of Frailty Phenotype (FP), Montreal Cognitive Assessment (MOCA), and Clinical Dementia Rating (CDR) scales being the most prevalent. Influencing factors were categorized into demographic and lifestyle, physical condition, disease-related and psychosocial aspects. Interventions included exercise, cognitive therapy combined with exercise, social support and predictive nursing, yet there remains a scarcity of intervention studies.</p><p><strong>Conclusion: </strong>The prevalence of CF in MHD patients is high; however, understanding of CF in MHD patients is insufficient. There are many types of assessment tools, but there is a lack of unified standards and specificity; the influencing factors are complex and diverse; and prevention and intervention studies are scarce.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-025-04361-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To conduct a scoping review of the related research on cognitive frailty (CF) in maintenance hemodialysis (MHD) patients, so as to provide a basis for early diagnosis, treatment and intervention of CF in MHD patients.
Methods: Utilizing a scoping review approach, we searched PubMed, Embase, The Cochrane Library, Web of Science, CINAHL, the China Biological Medicine Database (CBM), China National Knowledge Infrastructure (CNKI), Wanfang, and Weipu (VIP) for literature on CF in MHD patients up to October 20, 2024. Two researchers conducted independent screening and data extraction of the literature's fundamental characteristics. The study is registered in OSF ( https://doi.org/10.17605/OSF.IO/H6Q89 ).
Results: The review included 21 articles, revealing a concerningly high prevalence of CF in MHD patients, ranging from 4.6 to 56.4%. Six diagnostic combinations were identified, with the combination of Frailty Phenotype (FP), Montreal Cognitive Assessment (MOCA), and Clinical Dementia Rating (CDR) scales being the most prevalent. Influencing factors were categorized into demographic and lifestyle, physical condition, disease-related and psychosocial aspects. Interventions included exercise, cognitive therapy combined with exercise, social support and predictive nursing, yet there remains a scarcity of intervention studies.
Conclusion: The prevalence of CF in MHD patients is high; however, understanding of CF in MHD patients is insufficient. There are many types of assessment tools, but there is a lack of unified standards and specificity; the influencing factors are complex and diverse; and prevention and intervention studies are scarce.
目的:对维持性血液透析(MHD)患者认知衰弱(CF)的相关研究进行范围综述,为MHD患者CF的早期诊断、治疗和干预提供依据。方法:采用范围综述方法,检索PubMed、Embase、Cochrane Library、Web of Science、CINAHL、中国生物医学数据库(CBM)、中国知网(CNKI)、万方和唯普(VIP),检索截至2024年10月20日有关MHD患者CF的文献。两位研究者对文献的基本特征进行了独立筛选和数据提取。该研究已在OSF注册(https://doi.org/10.17605/OSF.IO/H6Q89)。结果:该综述包括21篇文章,揭示了MHD患者中CF的高患病率,从4.6到56.4%不等。确定了六种诊断组合,其中最普遍的是脆弱表型(FP)、蒙特利尔认知评估(MOCA)和临床痴呆评分(CDR)量表。影响因素分为人口和生活方式、身体状况、疾病相关和社会心理方面。干预措施包括锻炼、认知疗法结合锻炼、社会支持和预测性护理,但干预研究仍然缺乏。结论:MHD患者CF患病率较高;然而,对MHD患者的CF了解不足。评估工具种类繁多,但缺乏统一的标准和专用性;影响因素复杂多样;预防和干预研究很少。
期刊介绍:
International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.